Jane Street
CELU icon

Jane Street’s Celularity CELU Stock Holding History

Jane Street’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,310
Closed -$67K – 10333
2021
Q4 		$67K Sell
1,310
-470
-26% -$30K ﹤0.01% 9413
2021
Q3 		$126K Buy
+1,780
New +$144K ﹤0.01% 9166

Other funds holding CELU

CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

Jane Street's CELU Position: Q2 2026 in Review

Jane Street opened a new position in Celularity (CELU) in Q2 2026: 28,713 shares worth $17.2K. The stake represents ﹤0.01% of the portfolio and ranks #11241 among its holdings. This is a return to the name: Jane Street previously reported a position in CELU as recently as Q4 2025.

Jane Street first reported a position in CELU in Q3 2021 and has held it in 5 quarters since. The position peaked at $217K in Q3 2021. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

  • Jane Street held 28,713 shares of Celularity worth $17.2K as of Q2 2026.
  • Celularity was a new Jane Street position in Q2 2026.
  • Celularity made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11241 holding.
  • Jane Street first reported a position in Celularity in Q3 2021 and has held it in 5 quarters since.
  • Jane Street's Celularity position peaked at $217K in Q3 2021.
  • 39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.